Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06122246 · ClinicalTrials.gov registry record · NA

PRESSURE CHECK: Find Your Path to Better Health

A NA study of Blood Pressure, sponsored by Yale University.

Recruiting
Registry status
NA
Development phase
1,440
Enrollment target
4
Study locations

NCT06122246: Recruiting NA study of Blood Pressure, sponsored by Yale University.

NCT06122246 is a NA study of Blood Pressure that is actively recruiting participants, run by Yale University. The registered enrollment target is 1,440 participants, above the 273-participant average among 101 other Blood Pressure trials with a reported enrollment target (427% higher). The trial reports 4 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06122246, a NA study of Blood Pressure, is actively recruiting participants, sponsored by Yale University.

RECRUITING
Registry status
NA
Development phase
1,440 participants
Enrollment target
4
Study locations

Study Summary

This study seeks to develop the evidence for a sustainable, community-partnered, multi-level health system strategy to improve blood pressure control. Two team-based approaches are being tested: 1) a medical model of remote BP management (RBPM) alone, and 2) RBPM plus a social model with a community health worker (CHW). These 2 strategies are being compared with a standard community screening program with referral to primary care.

Primary Outcome

Participants will be assessed at 6 months for Blood Pressure (BP) control- defined as BP \<130/80 mmHg. To assess BP control, blood pressure will be measured in-person at the CBO (or another location) at Baseline, 6, 12 and 18 months with the primary endpoint of assessment as BP control at 6 months.

Conditions Studied

Interventions

  • BEHAVIORAL Community Health Worker (CHW)
  • OTHER Remote Blood Pressure (BP) Management Program (RBPM)

Study Locations (4)

Connecticut

  • Yale - New Haven

Massachusetts

  • Massachusetts General Brigham Hospital - Boston

Texas

  • Houston Methodist - Houston

Virginia

  • Sentara Health - Norfolk

Trial Details

FieldValue
Enrollment Target 1,440 participants
Start Date 2024-04-14
Est. Completion 2027-08-31
Phase NA
Yale University

1,492 total trials

What NCT06122246 shows while recruiting

NCT06122246 is an interventional study that assigns participants to a tested intervention. Its 1,440 participants enrollment target places it among the larger protocols in the corpus, above the 273-participant average among 101 other Blood Pressure trials with a reported enrollment target (427% higher).

The record links to 1 condition, with Blood Pressure appearing as the primary indexed condition, and to 2 interventions - of which Community Health Worker (CHW) is the first listed.

NCT06122246 reports a single indexed study location in Connecticut, Massachusetts, Texas.

Frequently Asked Questions

What is clinical trial NCT06122246 about?

NCT06122246 is a clinical study titled "PRESSURE CHECK: Find Your Path to Better Health". This study seeks to develop the evidence for a sustainable, community-partnered, multi-level health system strategy to improve blood pressure control. Two team-based approaches are being tested: 1) a medical model of remote BP management (RBPM) alone, and 2) RBPM plus a social model with a community...

What is the current status of trial NCT06122246?

This trial is currently recruiting. It is a NA study. The enrollment target is 1,440 participants. The study started on 2024-04-14. Estimated completion is 2027-08-31.

What conditions does trial NCT06122246 study?

This clinical trial studies the following conditions: Blood Pressure.

What interventions are being tested in trial NCT06122246?

The interventions under investigation include: Community Health Worker (CHW) (BEHAVIORAL), Remote Blood Pressure (BP) Management Program (RBPM) (OTHER).

Who is sponsoring clinical trial NCT06122246?

This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06122246 being conducted?

This trial has 4 study locations across Connecticut, Massachusetts, Texas, Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Blood Pressure

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06122246's enrollment target sits among peer trials

1,440 5th of 101 higher than 97 of 101 other Blood Pressure trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Blood Pressure trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04754022 · 1,440 participants · NA

    Transfusion Requirements in Younger Patients Undergoing Cardiac Surgery

  • NCT04989790 · 1,440 participants · NA

    Clinical Effectiveness of the "PICU Up!" Multifaceted Early Mobility Intervention for Critically Ill Children

  • NCT06324318 · 1,440 participants · Phase 2

    Parenting in 2 Worlds Multisite Trial

  • NCT06814509 · 1,440 participants · NA

    Delivering HOPE (Helping Women Optimize Prenatal Equity)

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06122246, the US trial registry maintained by the National Library of Medicine. NCT06122246 (large enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.